Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5'-O-(L-Prolylsulfamoyl)adenosine is a synthetic small molecule and a purine nucleoside analog. It is structurally related to adenosine but features a prolylsulfamoyl group at the 5' position of the ribose moiety. This compound acts as a stable analog of the aminoacyl adenylate intermediate formed during tRNA aminoacylation by aminoacyl-tRNA synthetases. Specifically, it mimics the prolyl-AMP intermediate and serves as a potent inhibitor of prolyl-tRNA synthetase (ProRS), an enzyme essential for protein synthesis in cells[1][6][9]. Its primary use has been in biochemical and structural studies to investigate enzyme mechanisms rather than as an approved therapeutic agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5'-O-(L-Prolylsulfamoyl)adenosine.